RE: Acacia stumblescabbie you are a piece of work. You obviously don't follow ACTG or you would know that analyst estimates for revs/eps for this Q were all over the place based on whether or not ACTG would book one or two big deals they are working on. There results were in line for example with JPM's analyst estimates which he posted two days ago. But you wouldn't know that.
Anywho here is what ACTG said on the cc (which I am certain you didn't listen in on). Lets compare it with what WIN did this past Q when they announce.
BTW did WIN's add of $4 to the MSD bid blow up your "model"? LoL!!!
===================================================
"Acacia had a great third quarter, as we continued to build our leadership position in patentlicensing. Acacia generated third quarter revenues and other operating income of $63 million, the
second highest grossing quarter in our company’s history. Revenues and other operating income
for the first nine months were a record $164 million, an increase of 38% over last year’s previous
record of $119 million.
Acacia completed 24 new licensing agreements in the third quarter, including agreements with
Advanced Micro Devices, Bank of America, Boston Scientific, Siemens, T-Mobile, and multiple
agreements with Research In Motion and RPX Corporation.
Acacia generated revenues from 22 different licensing programs in the quarter, including four new
licensing programs generating initial revenue. And we have now generated revenues from 108
different licensing programs. Acacia also acquired control of eight new patent portfolios for future
licensing in the quarter by partnering with patent owners, including 3G and 4G wireless patents
from a major telecommunications company, a patent portfolio relating to mobile applications for use
in smartphones and wireless computing devices, a patent portfolio relating to semiconductor
packaging technology, over 50 patents relating to semiconductor manufacturing processing
technology from a major technology company, patents for heart valve technology from a major
medical device company, and patents relating to document assembly for printers, domain name
registration technology and computer-aided design technology.
We continue to increase future shareholder value by partnering with patent owners, and now
control a record 192 different patent portfolios. Acacia also increased its cash and investments to a
record $319 million at the end of the quarter.